Manitol Labesfal

Mannitol, the active ingredient in Manitol Labesfal, is an osmotic diuretic presented as an injection solution for intravenous use. It is employed to lower elevated intracranial and intraocular pressures, to promote diuresis in acute kidney injury, and to protect renal function during procedures that involve nephrotoxic agents.

GNH USA supplies Manitol Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and research institutions worldwide. The company ensures product quality through strict regulatory compliance and cold‑chain logistics where required.

Manitol Labesfal, an osmotic diuretic, is used in clinical situations where rapid fluid shifts are needed to lower pressure or enhance renal clearance. - Elevated intracranial pressure: helps lower pressure to prevent brain herniation. - Elevated intraocular pressure: reduces pressure to protect optic nerve function. - Nephrotoxic procedures: provides renal protection by promoting diuresis. - Acute kidney injury: facilitates fluid removal and improves urine output.

Mannitol may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea or vomiting: gastrointestinal upset. - Thirst or dry mouth: due to osmotic effect. - Transient hypotension: drop in blood pressure after infusion. - Electrolyte imbalance: especially sodium and potassium shifts. - Tachycardia: increased heart rate.

Serious or Rare Side Effects: - Acute renal failure: worsening kidney function. - Pulmonary edema: fluid accumulation in lungs. - Severe hyponatremia: dangerously low serum sodium. - Anaphylactic reaction: rare allergic response. - Hemolysis: destruction of red blood cells. - Severe hypotension: marked drop in blood pressure requiring intervention.

Prior to using Manitol Labesfal, clinicians should consider several safety measures. - Renal function: assess baseline creatinine and urine output. - Electrolytes: monitor serum sodium and potassium levels. - Cardiovascular status: watch for signs of volume overload or hypotension. - Neurological status: observe intracranial pressure trends. - Pregnancy: use only if potential benefits justify potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause dehydration. - Insulin: may mask hypoglycemia symptoms. - ACE inhibitors: increased risk of renal impairment.

Moderate Interactions (Monitor Closely): - Nephrotoxic antibiotics (e.g., aminoglycosides): monitor renal function closely. - Antihypertensives: may enhance hypotensive effect. - Lithium: may raise serum lithium concentrations.